Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacia & Upjohn (PNU) -- Ignore unavailable to you. Want to Upgrade?

To: Chuck. Edwards who wrote (13)	8/11/1997 7:05:00 PM
From: Chuck. Edwards	Respond to of 43

Pharmacia held up nicely in today's big drug sell-off, even gaining ground as the rest of the drugs got hammered. This seems to confirm my belief that there is little downside in the stock.

To: Chuck. Edwards who wrote (13)	8/20/1997 1:07:00 PM
From: Quonnie	Respond to of 43

Chuck & Terry, I have been sandbagging this thread and I just picked up PFE @54.50 should have waited a bit longer because it dipped to $52. This company has the best pipeline of drugs at this moment. I have been tracking quite a few to include SGP,ABT, AHP,JNJ of which I own all of them. Some I am also watching is WLM but from looking at reports right now PFE looks the best even better than MRK. MRK is going to loose patents on some important drugs in the coming year which might hurt their earnings. Anyways this is my two cents worth good trading and hope the drug industry starts heading upward soon. Norm

To: Chuck. Edwards who wrote (13)	5/18/1998 4:20:00 PM
From: Dennis	Read Replies (2) \| Respond to of 43

Hi there, what happened to this thread?? Anyway the wife says that at the hospital where she works they are beginning a Phase III study using a drug called Linezolid. This is suppose to be a new one to fight all the drug resistant bugs out there. G+ infections. Anyone heard of this?? The trials begin June 9th to be exact. I heard a news report this morning on NPR about some company starting the same type of study but didn't catch the name of the company. Did anyone hear anything like this early this morning???? Thanks